MARITZA VIDAL

Dr. MARITZA VIDAL

Centro de Diagnóstico de Osteoporosis y Enfermedades Reumáticas (CEDOR), Lima, Peru
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2019 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
OMOsvaldo Daniel Messina
Osvaldo Daniel Messina
MARITZA VIDALMARITZA VIDAL
MARITZA VIDAL
LNLuis F. Vidal Neira
Luis F. Vidal Neira

12 December 2018 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
MARITZA VIDALMARITZA VIDAL
MARITZA VIDAL
RTRoss J. Thibodaux
Ross J. Thibodaux
LNLuis Fernando Vidal Neira
Luis Fernando Vidal Neira
OMOsvaldo Daniel Messina
Osvaldo Daniel Messina

22 March 2021 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
OMOsvaldo D. Messina
Osvaldo D. Messina
LVLuis Fernando Vidal
Luis Fernando Vidal
MARITZA VIDALMARITZA VIDAL
MARITZA VIDAL
IBIrene E. M. Bultink
Irene E. M. Bultink
HRHennie G. Raterman
Hennie G. Raterman
WLWilliam Lems
William Lems

9 November 2022 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
OMOsvaldo Daniel Messina
Osvaldo Daniel Messina
MARITZA VIDALMARITZA VIDAL
MARITZA VIDAL
JTJorge A Morales Torres
Jorge A Morales Torres
LVLuis Fernando Vidal
Luis Fernando Vidal
CAConstanza Arguissain
Constanza Arguissain
TPTalina Hernandez Pérez
Talina Hernandez Pérez

26 February 2021 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
MSMaria Florencia Scioscia
Maria Florencia Scioscia
MARITZA VIDALMARITZA VIDAL
MARITZA VIDAL
MSMarcelo Sarli
Marcelo Sarli
RGRodolfo Guelman
Rodolfo Guelman
KDKarina Danilowicz
Karina Danilowicz
MZMaría Belén Zanchetta
María Belén Zanchetta
Context Pregnancy- and lactation-associated osteoporosis (PLO) is a rare condition characterized by fragility fractures, mostly vertebral, during the third trimester of pregnancy or the early postpartum period. Objective The aim of this study was to evaluate bone microarchitecture in women with PLO to better understand the pathophysiology of this disease. Methods In this retrospective study, we included women with PLO referred to our bone center between November 2007 and July 2012. We assessed bone mineral density (BMD) by dual-energy x-ray absorptiometry, bone turnover markers, and bone microarchitecture by high-resolution peripheral quantitative computed tomography. Results were compared with a control group of healthy lactating women. Results Of the 7 primiparous patients with PLO, 6 suffered vertebral fractures and 1 developed a hip fracture during the seventh month of gestation. Fractures occurred within the eighth month of pregnancy and the fourth month post partum; vertebral fractures were multiple in 85.7%. Major or minor risk factors for osteoporosis were present in 86% of our patients. Trabecular density, number, and thickness were 34%, 20% and 22% lower than controls (P < .01, P = .01, and P = .01, respectively). Cortical parameters were also deteriorated but to a lesser extent. Conclusion In comparison with healthy lactating women, patients with PLO presented severe deterioration of bone trabecular and cortical microarchitecture. This significant compromise may explain the occurrence of multiple fractures in these otherwise healthy young women. Further prospective studies are needed to determine whether bone microarchitecture might be able to be restored in the future.

24 May 2023 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
OMOsvaldo D Messina
Osvaldo D Messina
MARITZA VIDALMARITZA VIDAL
MARITZA VIDAL
GAGiovanni Adami
Giovanni Adami
LVLuis Fernando Vidal
Luis Fernando Vidal
PCPatricia Clark
Patricia Clark
NLNancy E. Lane
Nancy E. Lane